Pond R Kelemen MD
Breast, Melanoma, Surgical Oncology (Other than Breast)
Associate Professor, Surgery, Zucker School of Medicine, Hofstra University
Join to View Full Profile
128 Ashford Ave# CommunitDobbs Ferry, NY 10522
Phone+1 914-693-5025
Fax+1 914-693-6351
Dr. Kelemen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Saint John’s Cancer Institute/Providence Saint John’s Health CenterFellowship, Complex General Surgical Oncology, 1996 - 1998
University of ChicagoResidency, Surgery, 1990 - 1996
University of Illinois College of Medicine at ChicagoResidency, Pathology-Anatomic and Clinical, 1987 - 1990
Stony Brook University Health Sciences Center School of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 2003 - 2026
MO State Medical License 1998 - 2004
CA State Medical License 1996 - 1998
IL State Medical License 1986 - 1996
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer Start of enrollment: 1999 Apr 01
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery Start of enrollment: 2012 May 18
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCombined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul
Surgical Oncology. 2022-12-01 - 3 citationsGenomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky
JCO Precision Oncology. 2022-09-01 - 6 citationsAge-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee
Annals of Surgical Oncology. 2022-04-04
Journal Articles
- Development of sentinel lymph node biopsy for melanomaPond Kelemen, Facial Plast Surg Clin North Am, 2/2003
Books/Book Chapters
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
